Published in PLoS Pathog on February 11, 2016
Three-dimensional structure of the 3'X-tail of hepatitis C virus RNA in monomeric and dimeric states. RNA (2017) 0.76
The chaperone-like activity of the hepatitis C virus IRES and CRE elements regulates genome dimerization. Sci Rep (2017) 0.75
Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation. Oncotarget (2017) 0.75
Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. Front Microbiol (2017) 0.75
Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31
A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74
A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci (2004) 4.84
Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci (1992) 4.64
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol (2007) 4.28
Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology (1999) 3.83
Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog (2008) 3.81
Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly. Nat Med (2013) 3.24
Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol (2005) 3.21
Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog (2007) 2.98
Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol (2008) 2.74
NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol (2008) 2.62
Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. J Virol (2002) 2.62
3' nontranslated RNA signals required for replication of hepatitis C virus RNA. J Virol (2003) 2.41
Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol (1999) 2.38
Assembly of infectious hepatitis C virus particles. Trends Microbiol (2010) 2.36
Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J Virol (2001) 1.84
Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol (2008) 1.70
The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J Virol (2008) 1.70
Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J Virol (2010) 1.66
3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol (2007) 1.62
CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol (2007) 1.61
Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog (2009) 1.56
NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog (2011) 1.52
Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A. J Virol (2005) 1.47
Are there any subgenomic forms of hepatitis C virus RNA in the liver? Dig Liver Dis (2001) 1.40
Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host Microbe (2014) 1.22
Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets. PLoS Pathog (2013) 1.10
Packaging of brome mosaic virus subgenomic RNA is functionally coupled to replication-dependent transcription and translation of coat protein. J Virol (2006) 1.10
Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution. J Virol (2011) 1.10
Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J Virol (2010) 1.10
Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production. J Virol (2014) 1.00
A twist in the tail: SHAPE mapping of long-range interactions and structural rearrangements of RNA elements involved in HCV replication. Nucleic Acids Res (2012) 0.96
Role of RNA structures in genome terminal sequences of the hepatitis C virus for replication and assembly. J Virol (2009) 0.94
Hepatitis C virus 3'UTR regulates viral translation through direct interactions with the host translation machinery. Nucleic Acids Res (2013) 0.93
Signal peptidase complex subunit 1 participates in the assembly of hepatitis C virus through an interaction with E2 and NS2. PLoS Pathog (2013) 0.92
Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions? Nucleic Acids Res (2012) 0.92
The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release. J Gen Virol (2013) 0.92
End-to-end crosstalk within the hepatitis C virus genome mediates the conformational switch of the 3'X-tail region. Nucleic Acids Res (2013) 0.89
Genetic complementation of hepatitis C virus nonstructural protein functions associated with replication exhibits requirements that differ from those for virion assembly. J Virol (2013) 0.82
Detection of a 5' end subgenome of hepatitis C virus terminating at nucleotide 384 in patients' plasma and liver tissues. J Viral Hepat (2006) 0.81
Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen. J Biomol Screen (2015) 0.81
Complete Genome Sequence of a Novel GV.2 Sapovirus Strain, NGY-1, Detected from a Suspected Foodborne Gastroenteritis Outbreak. Genome Announc (2015) 1.57
Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation. PLoS One (2015) 1.39
The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model. PLoS Pathog (2015) 1.03
Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles. PLoS Pathog (2014) 0.93
Hepatitis virus infection affects DNA methylation in mice with humanized livers. Gastroenterology (2013) 0.92
Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells. J Virol (2014) 0.89
Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. Am J Pathol (2015) 0.87
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide. J Virol (2015) 0.84
Alternative endocytosis pathway for productive entry of hepatitis C virus. J Gen Virol (2014) 0.84
Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells. Gastroenterology (2014) 0.81
Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model. J Virol (2015) 0.80
Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. Sci Rep (2015) 0.80
Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus. PLoS Pathog (2016) 0.79
Hepatitis C virus nonstructural protein 5A inhibits thapsigargin-induced apoptosis. PLoS One (2014) 0.78
Characterization of self-assembled virus-like particles of Merkel cell polyomavirus. PLoS One (2015) 0.78
Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus. J Virol (2014) 0.78
Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney. MBio (2016) 0.77
Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection. PLoS One (2014) 0.77
Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan. Vaccine (2015) 0.77
Hepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation. J Virol (2016) 0.76
Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A. J Med Virol (2016) 0.76
Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents. Sci Rep (2016) 0.76
Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C. PLoS One (2015) 0.75
Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey. Int J Infect Dis (2015) 0.75
Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System. J Virol (2016) 0.75
Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production. J Virol (2016) 0.75
Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka. Am J Trop Med Hyg (2016) 0.75
Novel Autoantigens Associated with Lupus Nephritis. PLoS One (2015) 0.75
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy. PLoS One (2017) 0.75
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep (2016) 0.75
HTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin Chains. PLoS Pathog (2017) 0.75
Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment. Sci Rep (2017) 0.75
A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins. Hepatology (2016) 0.75
Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation. Oncotarget (2017) 0.75
Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model. Gut (2016) 0.75
Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. Virus Res (2019) 0.75
Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes. J Gastroenterol (2017) 0.75
Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae. PLoS Pathog (2017) 0.75
Identification of Micro RNA Associated with the Elimination of Hepatitis C Virus Genotype 1b by Direct-Acting Antivirals Therapies. J Gastroenterol Hepatol (2020) 0.75
Retinoids and rexinoids inhibit hepatitis C virus independently of retinoid receptor signaling. Microbes Infect (2013) 0.75
Functional Correlation between Subcellular Localizations of Japanese Encephalitis Virus Capsid Protein and Virus Production. J Virol (2019) 0.75
Characterization of miR-122-independent propagation of HCV. PLoS Pathog (2017) 0.75
Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation. Oncotarget (2017) 0.75